BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37385941)

  • 1. Efficacy and long-term prognosis of gastrojejunostomy for malignant gastric outlet obstruction: A systematic review and Bayesian network meta-analysis.
    Wang C; Zhang X; Liu Y; Lin S; Yang C; Chen B; Li W
    Eur J Surg Oncol; 2023 Nov; 49(11):106967. PubMed ID: 37385941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of malignant Gastric Outlet Obstruction (mGOO) due to pancreatic cancer in the era of EUS-Gastrojejunostomy: an international practice survey and case vignette study by Pancreas 2000 from the European Pancreatic Club.
    De Ponthaud C; Bozkirli B; Rizzo GEM; Robinson S; Vilas-Boas F; Capurso G; Gaujoux S; Vanella G
    Surg Endosc; 2024 Jun; 38(6):3231-3240. PubMed ID: 38649494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative gastrojejunostomy versus endoscopic stent placement for gastric outlet obstruction in patients with unresectable gastric cancer: a propensity score-matched analysis.
    Jang SH; Lee H; Min BH; Kim SM; Kim HS; Carriere KC; Min YW; Lee JH; Kim JJ
    Surg Endosc; 2017 Oct; 31(10):4217-4223. PubMed ID: 28281127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gastrojejunostomy to endoscopic stenting for gastric outlet obstruction: An updated Systematic Review and Meta-analysis.
    Hong J; Chen Y; Li J; Hu P; Chen P; Du N; Huang T; Chen J
    Am J Surg; 2022 Jun; 223(6):1067-1078. PubMed ID: 34728070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrojejunostomy versus endoscopic stenting for the palliation of malignant gastric outlet obstruction: a systematic review and meta-analysis.
    Khamar J; Lee Y; Sachdeva A; Anpalagan T; McKechnie T; Eskicioglu C; Agzarian J; Doumouras A; Hong D
    Surg Endosc; 2023 Jun; 37(6):4834-4868. PubMed ID: 36138247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review of Endoscopic Treatments for Concomitant Malignant Biliary Obstruction and Malignant Gastric Outlet Obstruction and the Outstanding Role of Endoscopic Ultrasound-Guided Therapies.
    Rizzo GEM; Carrozza L; Quintini D; Ligresti D; Traina M; Tarantino I
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Palliative Gastrojejunostomy for Malignant Gastric Outlet Obstruction an Optimal Choice for Very Elderly Patients? A Report from a Long-Lived Country.
    Yao S; Kita R; Ishikawa K; Kumode T; Tanino K; Mizuno R; Matsui Y; Honma S; Murakami T; Kan T; Nakajima S; Kaihara S; Harada T
    Ann Surg Oncol; 2023 Jan; 30(1):313-321. PubMed ID: 36171530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative surgical bypass is superior to palliative endoscopic stenting in patients with malignant gastric outlet obstruction: systematic review and meta-analysis.
    Mintziras I; Miligkos M; Wächter S; Manoharan J; Bartsch DK
    Surg Endosc; 2019 Oct; 33(10):3153-3164. PubMed ID: 31332564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stenting versus gastrojejunostomy for management of malignant gastric outlet obstruction: comparison of clinical outcomes and costs.
    Roy A; Kim M; Christein J; Varadarajulu S
    Surg Endosc; 2012 Nov; 26(11):3114-9. PubMed ID: 22549377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Meta-Analysis of Endoscopic Stenting Versus Surgical Treatment for Malignant Gastric Outlet Obstruction.
    Del Nero L; Sheijani AD; De Ceglie A; Bruzzone M; Ceppi M; Filiberti RA; Siersema P; Conio M
    World J Surg; 2023 Jun; 47(6):1519-1529. PubMed ID: 36869171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic ultrasound guided gastrojejunostomy in the treatment of gastric outlet obstruction: multi-centre experience from the United Kingdom.
    On W; Huggett MT; Young A; Pine J; Smith AM; Tehami N; Maher B; Pereira SP; Johnson G; Paranandi B
    Surg Endosc; 2023 Mar; 37(3):1749-1755. PubMed ID: 36217058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteral stenting versus gastrojejunostomy for palliation of malignant gastric outlet obstruction.
    Khashab M; Alawad AS; Shin EJ; Kim K; Bourdel N; Singh VK; Lennon AM; Hutfless S; Sharaiha RZ; Amateau S; Okolo PI; Makary MA; Wolfgang C; Canto MI; Kalloo AN
    Surg Endosc; 2013 Jun; 27(6):2068-75. PubMed ID: 23299137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and cost analysis of surgical bypass versus endoscopic stenting for the palliative management of malignant gastric outlet obstruction.
    Fisher AV; Hanlon B; Fernandes-Taylor S; Schumacher JR; Lawson EH; Ronnekleiv-Kelly SM; Minter RM; Weber SM; Abbott DE
    HPB (Oxford); 2020 Apr; 22(4):529-536. PubMed ID: 31519358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between initial management strategy and survival in patients with gastric outlet obstruction due to gastric cancer.
    Blumenthaler AN; Ikoma N; Blum M; Das P; Minsky BD; Mansfield PF; Ajani JA; Badgwell BD
    J Surg Oncol; 2020 Dec; 122(7):1373-1382. PubMed ID: 32810292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction-a systematic review and meta-analysis of randomized and non-randomized trials.
    Nagaraja V; Eslick GD; Cox MR
    J Gastrointest Oncol; 2014 Apr; 5(2):92-8. PubMed ID: 24772336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis.
    Brandão M; Maurer C; Ziegelmann PK; Pondé NF; Ferreira A; Martel S; Piccart M; de Azambuja E; Debiasi M; Lambertini M
    ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32847835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis.
    Zhan ZJ; Yao WY; Zhang F; Qiu WZ; Liao K; Feng JH; Tan JY; Liu H; Yuan TZ; Zheng RH; Yuan YW
    Front Immunol; 2021; 12():719650. PubMed ID: 34413862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.